Clinical Trial Update: A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of ALG-000184 after single and multiple doses in healthy volunteers and chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ALG-000184

Snippet

Sponsor: Aligos Therapeutics | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED